Aspen Aerogels (NYSE: ASPN) reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $78.72 million versus the consensus estimate of $82.74 million.

GUIDANCE:

Aspen Aerogels sees Q2 2025 EPS of $0.13-$0.05, versus the consensus of $0.03. Aspen Aerogels sees Q2 2025 revenue of $70-80 million, versus the consensus of $90.87 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.